ketanserin has been researched along with interleukin-8 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, SC; Ip, MS; Lau, WK; Law, AC; Mak, JC | 1 |
1 other study(ies) available for ketanserin and interleukin-8
| Article | Year |
|---|---|
The role of MAPK and Nrf2 pathways in ketanserin-elicited attenuation of cigarette smoke-induced IL-8 production in human bronchial epithelial cells.
Topics: Anti-Inflammatory Agents; Antioxidants; Bronchi; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Glutathione; Humans; Interleukin-8; Ketanserin; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NF-E2-Related Factor 2; Oxidation-Reduction; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Receptor, Serotonin, 5-HT2A; RNA Interference; RNA, Messenger; Serotonin 5-HT2 Receptor Antagonists; Smoke; Smoking; Time Factors; Transfection; Up-Regulation | 2012 |